Rapid Tests Kits Market

Global Rapid Tests Kits Market By Product (Over-the-Counter (OTC), and Professional), By Application (Infectious Disease (HPV Rapid Tests Kits, Hepatitis Rapid Tests Kits, Influenza Rapid Tests Kits, Malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID – 19, and Other Infectious Disease Rapid Tests Kits), Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Home Care, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Report ID: HC-3837
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 266
  • Format:
  • Pub. Date: 22-01-2022
  • Share:

Market Outlook:

The Global Rapid Tests Kits Market was valued at USD xx million in 2020 and is projected to reach USD xx million by 2028, expanding at a CAGR of xx% during the forecast period. Food goods are tested for infections, meat speciation, GMOs, allergies, pesticides, mycotoxins, heavy metals, and other contaminants using Rapid Tests Kits. The market for Rapid Tests Kits is being driven by the increased demand for both faster and quantitative test results to assure food safety. Market companies are increasing their global footprint and service offerings in response to these new prospects.

Rapid Tests Kits, also known as rapid diagnostic tests (RDTs), are easy to use and typically provide results within 20 minutes. These tests are useful for conducting preliminary screening. In particular, Rapid Tests Kits are useful in settings where resources are limited. A rapid antigen test can be administered for individuals with or without COVID-19 symptoms. These tests include the collection nose and throat secretions using nasopharyngeal swab and then examining them for protein fragments specific to the COVID-19 virus. Rapid antigen tests are most reliable when people are in the early stages of COVID-19, when the viral load is highest in the throat and nasal passages. The government has shipped millions of rapid COVID tests to nursing homes, schools, and other facilities. Rapid COVID tests are available at other point-of-care facilities, such as pharmacies.

COVID-19 did not hamper the Rapid Tests Kits market, as these tests are widely used in the healthcare sector. Manufacturers in the market were focused on investing in R&D activities, which drove the market during the pandemic. Growing R&D activities increased for COVID-19 pandemic, which is expected to fuel the market. Researchers in several countries are working on creating effective and affordable Rapid Tests Kits to detect COVID-19 in people. These developments are expected to significantly propel the healthcare sector. Many major players and some startups from various countries have introduced COVID-19 diagnostic kits. This, in turn, is expected to propel the global Rapid Tests Kits market during the forecast period.

Rapid Tests Kits Market by outlook

Scope of the Report

The report on the Global Rapid Tests Kits market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Global Rapid Tests Kits Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

By Product (Over-the-Counter (OTC), and Professional), By Application (Infectious Disease (HPV Rapid Tests Kits, Hepatitis Rapid Tests Kits, Influenza Rapid Tests Kits, Malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID – 19, and Other Infectious Disease Rapid Tests Kits), Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Home Care, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

Abbott, BD, Bio-Rad Laboratories, Inc., Cepheid, Meridian Bioscience, Inc., OraSure Technologies, Quidel Corporation, F. Hoffmann-La Roche Ltd. , VedaLab, Atlas Medical GmbH, Abingdon Health, Vitrosens Biotechnology, Advin Health care, Rapikit, and MP Biomedicals.

 

Market Dynamics

Increasing Prevalence of Infectious Diseases

A rapid test is widely used in diagnosing infectious diseases such as HIV, malaria, influenza, flu, HPV, hepatitis, and strep throat. Rapid Tests Kits are widely adopted for preliminary screening and increasing incidences of infections such as hepatitis, HIV, and HPV, thus propelling the global Rapid Tests Kits market during the forecast period. Lateral-flow and immunochromatographic Rapid Tests Kits are used to detect certain infections, as these are point-of-care (POC) tests. Increasing incidences of infectious diseases is projected to fuel the Rapid Tests Kits market during the forecast period.

Sudden Outbreak & Spread of COVID-19

Several people were infected by the COVID-19 virus, which significantly changed the scenario of healthcare infrastructure across the world. Governments, healthcare companies, and institutions have developed multiple COVID-19 rapid test kits. For instance, in 2020, Cipla Inc. partnered with Premier Medical Corporation Private Limited for the commercialization of the rapid antigen detection test kits in India, which detects the COVID-19 virus within 15 to 20 minutes. Additionally, governments around the world, such as the UK Government developed nationwide COVID-19 testing program with the help of rapid test kits.

Growing Preference for Home Healthcare

Governments have imposed strict lockdown and restrictions on traveling and movement of goods & services due to the spread the COVID-19 pandemic worldwide. The fear of contracting and spreading the virus made people across the globe adopt home-based healthcare treatment. People avoided visiting healthcare facilities such as diagnostic centers and hospitals & clinics. They preferred using rapid test kits at home for pregnancy/fertility testing and glucose monitoring. People started using rapid antibody and antigen kits for COVID-19 testing at homes, which in turn, propelled the market.

Rising Geriatric Population

According to the United Nation Population Division of the Department of Economic and Social Affairs, the number of people aged 65 years or above was 703 million in 2019 and this number is anticipated to rise to 120% between 2019 and 2050. This number is expected to reach 1548.9 million by 2050. Growing geriatric population, exposed to various kinds of non-communicable and communicable diseases, is anticipated to drive the market in the coming years. Rapid test kits are used for glucose monitoring, thus propelling the market during the forecast period.

Increasing Healthcare Expenditure

The expenditure on healthcare is growing across different countries, which is projected to improve the existing medical and healthcare devices market. This is anticipated to fuel the market by 2028. According to the WHO, the global spending on healthcare was around USD 8.3 trillion in 2018, which was about 10% of the global economy. This spending is projected to increase significantly in the coming years. The demand for healthcare services has increased due to the sudden outbreak and spread of the COVID-19 virus. This expenditure is expected to increase in the coming years due to the rising demand for other healthcare services and medical devices, thereby creating opportunities in the global rapid test kit market.

Segmental Outlook

The Global Rapid Tests Kits market is segmented on the basis of Product, Application, End-user, and regions.

Based on products, the Rapid Tests Kits market is bifurcated into Over-the-Counter (OTC), and Professional. At present, the Over-the-Counter (OTC) rapid test product segment contributes for the highest market share among all products, and is anticipated to continue to remain dominant during the forecast period majorly due to the rise in incidence of diabetes. Also factors such as rise in preliminary screening procedures in hospitals and surge in adoption of Rapid Tests Kits in the developing regions of Asia and Africa drive the growth of the professional rapid test products market.

Rapid Tests Kits Market by products

Based on applications, the global Rapid Tests Kits market is segmented into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. The infectious disease segment is further categorized into HPV Rapid Tests Kits, hepatitis Rapid Tests Kits, influenza Rapid Tests Kits, malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID-19 Rapid Tests Kits, and other infectious disease Rapid Tests Kits. During the projected period, the infectious disease rapid testing market is expected to develop at the fastest rate. The global infectious disease quick tests market is growing due to an increase in the usage of Rapid Tests Kits for preliminary screening and an increase in the incidence of illnesses such as HIV, HPV, hepatitis, and others. Glucose monitoring is the greatest revenue contributor at the moment, and it is expected to continue to dominate the market over the projection period. The market's growth is fueled by the easy availability of low-cost products, a large diabetes population, and an increase in the use of glucose monitoring fast testing devices among the general population.

Rapid Tests Kits Market by applications

Based on end-users, the global Rapid Tests Kits market is classified as hospitals & clinics, diagnostic, laboratories, homecare, and others. The diagnostic segment is estimated to holds a significant market share during the forecast period, as these center conduct various types of test such as COVID-19, HIV, glucose monitoring, and HPV. The homecare segment is expected to account for a considerable share of the rapid test market in the coming years due to the spread of Coronavirus pandemic and rising awareness regarding the at-home test kits such as glucose monitoring. The others segment is expected to hold a substantial market share and is anticipated to grow during the forecast period.

Rapid Tests Kits Market by end users

Regional Outlook

Based on regions, the global Rapid Tests Kits market is fragmented into North America, Europe, Latin America, and Middle East & Africa. The market in North America is projected to expand at a significant CAGR during the forecast period, owing to increasing use of rapid antigen test kits at home. The US is expected to account for a significant share of the market in the region during the forecast period. In the US, allergies are the sixth leading cause of chronic illness. To help ensure that the people in the country have COVID-19 tests on hand, if a need arises, the Biden Administration has purchased one billion at-home, rapid COVID-19 tests to give to provide the citizens for free. Asia-Pacific presents lucrative opportunities for the players operating in the Rapid Tests Kits market, on account of its high population base, increase in disposable incomes, and growth in awareness about advance Rapid Tests Kits. Furthermore, the fast test market is growing due to an increase in the incidence of various diseases and an increase in R&D spending in developing nations such as India, China, and Brazil.

Rapid Tests Kits Market by regions

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Rapid Tests Kits Market
  • Historical, Current, and Projected Market Size in terms of Value and Volume
  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
  • Industry Drivers, Restraints, and Opportunities Covered in the Study
  • Recent Industry Trends and Developments
  • Competitive Landscape & Strategies of Key Players
  • Neutral Perspective on Global Rapid Tests Kits Market Performance

Segments

Key Segments Covered

By Products

  • Over-the-Counter (OTC)
  • Professional
By Application
  • Infectious Disease
    • HPV Rapid Tests Kits
    • Hepatitis Rapid Tests Kits
    • Influenza Rapid Tests Kits
    • Malaria Rapid Tests Kits
    • HIV Rapid Tests Kits
    • COVID – 19
    • Other Infectious Disease Rapid Tests Kits
  • Cardiology
  • Oncology
  • Pregnancy & Fertility
  • Toxicology
  • Glucose Monitoring
  • Others
By End-user
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Others
Key Market Players Profiled in the Report
  • Abbott
  • BD
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Meridian Bioscience, Inc.
  • OraSure Technologies
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd.
  • VedaLab
  • Atlas Medical GmbH
  • Abingdon Health
  • Vitrosens Biotechnology
  • Advin Health care
  • Rapikit
  • MP Biomedicals

Competitive Landscape

  • Key players operating in the market are Abbott, BD, Bio-Rad Laboratories, Inc., Cepheid, Meridian Bioscience, Inc., OraSure Technologies, Quidel Corporation, F. Hoffmann-La Roche Ltd. , VedaLab, Atlas Medical GmbH, Abingdon Health, Vitrosens Biotechnology, Advin Health care, Rapikit, and MP Biomedicals. These companies are considered as key manufacturers of rapid test based on their revenue, research development (R&D) activities, product offerings, regional presence, and supply chain management system.
  • The players are adopting key strategies such as acquisition, collaborations, and geographical expansion where potential opportunity for the rapid test market.
  • On December 26, 2020, Abbott’s Binaxnow Covid-19 rapid test received FDA emergency use authorization for first virtually guided, at-home rapid test using EMED'S digital health platform.
  • On February 22 2021, BD collaborated with Scanwell Health for at-home rapid test for Covid-19, using a BD antigen test and the Scanwell Health mobile app.
  •  On March 30 2021, BD received FDA emergency use authorization for BD Veritor System, which is a rapid antigen test that can detect SARS-CoV-2, influenza A, and influenza B in a single test.
Rapid Tests Kits Market by key players
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rapid Tests Kits Market Overview
  4.1 Introduction
   4.1.1 Market Taxonomy
   4.1.2 Market Definition
   4.1.3 Macro-Economic Factors Impacting the Market Growth
  4.2 Rapid Tests Kits Market Dynamics
   4.2.1 Market Drivers
   4.2.2 Market Restraints
   4.2.3 Market Opportunity
  4.3 Rapid Tests Kits Market- Supply Chain Analysis
   4.3.1 List of Key Suppliers
   4.3.2 List of Key Distributors
   4.3.3 List of Key Consumers
  4.4 Key Forces Shaping the Rapid Tests Market
   4.4.1 Bargaining Power of Suppliers
   4.4.2 Bargaining Power of Buyers
   4.4.3 Threat of Substitution
   4.4.4 Threat of New Entrants
   4.4.5 Competitive Rivalry
  4.5 Global Rapid Tests Kits Market Size & Forecast, 2018-2028
   4.5.1 Rapid Tests Kits Market Size and Y-o-Y Growth
   4.5.2 Rapid Tests Kits MarketAbsolute $ Opportunity
  4.6 Environmental Threat Opportunity Profile (ETOP) Analysis
  4.7 Market Entry Strategies
  4.8 Current & Future Trends
  4.9 PESTEL Analysis
  4.10 Pipeline/Clinical Trial Analysis
  4.11 Pre & Post-COVID Scenario
  4.12 Technology Outlook Trends/Disruptions Impacting Customers’ Businesses
  4.13 Regulation Overview
Chapter 5 Global Rapid Tests Kits Market Analysis and Forecast By Product
  5.1 Introduction
   5.1.1 Key Market Trends & Growth Opportunities By Product
   5.1.2 Basis Point Share (BPS) Analysis By Product
   5.1.3 Absolute $ Opportunity Assessment By Product
  5.2 Rapid Tests Kits Market Size Forecast By Product
   5.2.1 Over-the-counter (OTC)
   5.2.2 Professional
  5.3 Market Attractiveness Analysis By Product
Chapter 6 Global Rapid Tests Kits Market Analysis and Forecast By Application
  6.1 Introduction
   6.1.1 Key Market Trends & Growth Opportunities By Application
   6.1.2 Basis Point Share (BPS) Analysis By Application
   6.1.3 Absolute $ Opportunity Assessment By Application
  6.2 Rapid Tests Kits Market Size Forecast By Application
   6.2.1 Infectious Disease
     6.2.1.1 HPV Rapid Tests
     6.2.1.2 Hepatitis Rapid Tests
     6.2.1.3 Influenza Rapid Tests
     6.2.1.4 Malaria Rapid Tests
     6.2.1.5 HIV Rapid Tests
     6.2.1.6 COVID - 19
     6.2.1.7 Other Infectious Disease Rapid Tests
   6.2.2 Cardiology
   6.2.3 Oncology
   6.2.4 Pregnancy & Fertility
   6.2.5 Toxicology
   6.2.6 Glucose Monitoring
   6.2.7 Others
  6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Rapid Tests Kits Market Analysis and Forecast By End-user
  7.1 Introduction
   7.1.1 Key Market Trends & Growth Opportunities By End-user
   7.1.2 Basis Point Share (BPS) Analysis By End-user
   7.1.3 Absolute $ Opportunity Assessment By End-user
  7.2 Rapid Tests Kits Market Size Forecast By End-user
   7.2.1 Hospitals & clinics
   7.2.2 Diagnostic laboratories
   7.2.3 Home care
   7.2.4 Others
  7.3 Market Attractiveness Analysis By End-user
Chapter 8 Global Rapid Tests Kits Market Analysis and Forecast by Region
  8.1 Introduction
   8.1.1 Key Market Trends & Growth Opportunities by Region
   8.1.2 Basis Point Share (BPS) Analysis by Region
   8.1.3 Absolute $ Opportunity Assessment by Region
  8.2 Rapid Tests Kits Market Size Forecast by Region
   8.2.1 North America
   8.2.2 Europe
   8.2.3 Asia Pacific
   8.2.4 Latin America
   8.2.5 Middle East & Africa (MEA)
  8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
  9.1 Introduction
  9.2 Current & Future Impact Analysis
  9.3 Economic Impact Analysis
  9.4 Government Policies
  9.5 Investment Scenario
Chapter 10 North America Rapid Tests Kits Analysis and Forecast
  10.1 Introduction
  10.2 North America Rapid Tests Kits Market Size Forecast by Country
   10.2.1 U.S.
   10.2.2 Canada
  10.3 Basis Point Share (BPS) Analysis by Country
  10.4 Absolute $ Opportunity Assessment by Country
  10.5 Market Attractiveness Analysis by Country
  10.6 North America Rapid Tests Kits Market Size Forecast By Product
   10.6.1 Over-the-counter (OTC)
   10.6.2 Professional
  10.7 Basis Point Share (BPS) Analysis By Product
  10.8 Absolute $ Opportunity Assessment By Product
  10.9 Market Attractiveness Analysis By Product
  10.10 North America Rapid Tests Kits Market Size Forecast By Application
   10.10.1 Infectious Disease
     10.10.1.1 HPV Rapid Tests
     10.10.1.2 Hepatitis Rapid Tests
     10.10.1.3 Influenza Rapid Tests
     10.10.1.4 Malaria Rapid Tests
     10.10.1.5 HIV Rapid Tests
     10.10.1.6 COVID - 19
     10.10.1.7 Other Infectious Disease Rapid Tests
   10.10.2 Cardiology
   10.10.3 Oncology
   10.10.4 Pregnancy & Fertility
   10.10.5 Toxicology
   10.10.6 Glucose Monitoring
   10.10.7 Others
  10.11 Basis Point Share (BPS) Analysis By Application
  10.12 Absolute $ Opportunity Assessment By Application
  10.13 Market Attractiveness Analysis By Application
  10.14 North America Rapid Tests Kits Market Size Forecast By End-user
   10.14.1 Hospitals & clinics
   10.14.2 Diagnostic laboratories
   10.14.3 Home care
   10.14.4 Others
  10.15 Basis Point Share (BPS) Analysis By End-user
  10.16 Absolute $ Opportunity Assessment By End-user
  10.17 Market Attractiveness Analysis By End-user
Chapter 11 Europe Rapid Tests Kits Analysis and Forecast
  11.1 Introduction
  11.2 Europe Rapid Tests Kits Market Size Forecast by Country
   11.2.1 Germany
   11.2.2 France
   11.2.3 Italy
   11.2.4 U.K.
   11.2.5 Spain
   11.2.6 Russia
   11.2.7 Rest of Europe
  11.3 Basis Point Share (BPS) Analysis by Country
  11.4 Absolute $ Opportunity Assessment by Country
  11.5 Market Attractiveness Analysis by Country
  11.6 Europe Rapid Tests Kits Market Size Forecast By Product
   11.6.1 Over-the-counter (OTC)
   11.6.2 Professional
  11.7 Basis Point Share (BPS) Analysis By Product
  11.8 Absolute $ Opportunity Assessment By Product
  11.9 Market Attractiveness Analysis By Product
  11.10 Europe Rapid Tests Kits Market Size Forecast By Application
   11.10.1 Infectious Disease
     11.10.1.1 HPV Rapid Tests
     11.10.1.2 Hepatitis Rapid Tests
     11.10.1.3 Influenza Rapid Tests
     11.10.1.4 Malaria Rapid Tests
     11.10.1.5 HIV Rapid Tests
     11.10.1.6 COVID - 19
     11.10.1.7 Other Infectious Disease Rapid Tests
   11.10.2 Cardiology
   11.10.3 Oncology
   11.10.4 Pregnancy & Fertility
   11.10.5 Toxicology
   11.10.6 Glucose Monitoring
   11.10.7 Others
  11.11 Basis Point Share (BPS) Analysis By Application
  11.12 Absolute $ Opportunity Assessment By Application
  11.13 Market Attractiveness Analysis By Application
  11.14 Europe Rapid Tests Kits Market Size Forecast By End-user
   11.14.1 Hospitals & clinics
   11.14.2 Diagnostic laboratories
   11.14.3 Home care
   11.14.4 Others
  11.15 Basis Point Share (BPS) Analysis By End-user
  11.16 Absolute $ Opportunity Assessment By End-user
  11.17 Market Attractiveness Analysis By End-user
Chapter 12 Asia Pacific Rapid Tests Kits Analysis and Forecast
  12.1 Introduction
  12.2 Asia Pacific Rapid Tests Kits Market Size Forecast by Country
   12.2.1 China
   12.2.2 Japan
   12.2.3 South Korea
   12.2.4 India
   12.2.5 Australia
   12.2.6 South East Asia (SEA)
   12.2.7 Rest of Asia Pacific (APAC)
  12.3 Basis Point Share (BPS) Analysis by Country
  12.4 Absolute $ Opportunity Assessment by Country
  12.5 Market Attractiveness Analysis by Country
  12.6 Asia Pacific Rapid Tests Kits Market Size Forecast By Product
   12.6.1 Over-the-counter (OTC)
   12.6.2 Professional
  12.7 Basis Point Share (BPS) Analysis By Product
  12.8 Absolute $ Opportunity Assessment By Product
  12.9 Market Attractiveness Analysis By Product
  12.10 Asia Pacific Rapid Tests Kits Market Size Forecast By Application
   12.10.1 Infectious Disease
     12.10.1.1 HPV Rapid Tests
     12.10.1.2 Hepatitis Rapid Tests
     12.10.1.3 Influenza Rapid Tests
     12.10.1.4 Malaria Rapid Tests
     12.10.1.5 HIV Rapid Tests
     12.10.1.6 COVID - 19
     12.10.1.7 Other Infectious Disease Rapid Tests
   12.10.2 Cardiology
   12.10.3 Oncology
   12.10.4 Pregnancy & Fertility
   12.10.5 Toxicology
   12.10.6 Glucose Monitoring
   12.10.7 Others
  12.11 Basis Point Share (BPS) Analysis By Application
  12.12 Absolute $ Opportunity Assessment By Application
  12.13 Market Attractiveness Analysis By Application
  12.14 Asia Pacific Rapid Tests Kits Market Size Forecast By End-user
   12.14.1 Hospitals & clinics
   12.14.2 Diagnostic laboratories
   12.14.3 Home care
   12.14.4 Others
  12.15 Basis Point Share (BPS) Analysis By End-user
  12.16 Absolute $ Opportunity Assessment By End-user
  12.17 Market Attractiveness Analysis By End-user
Chapter 13 Latin America Rapid Tests Kits Analysis and Forecast
  13.1 Introduction
  13.2 Latin America Rapid Tests Kits Market Size Forecast by Country
   13.2.1 Brazil
   13.2.2 Mexico
   13.2.3 Rest of Latin America (LATAM)
  13.3 Basis Point Share (BPS) Analysis by Country
  13.4 Absolute $ Opportunity Assessment by Country
  13.5 Market Attractiveness Analysis by Country
  13.6 Latin America Rapid Tests Kits Market Size Forecast By Product
   13.6.1 Over-the-counter (OTC)
   13.6.2 Professional
  13.7 Basis Point Share (BPS) Analysis By Product
  13.8 Absolute $ Opportunity Assessment By Product
  13.9 Market Attractiveness Analysis By Product
  13.10 Latin America Rapid Tests Kits Market Size Forecast By Application
   13.10.1 Infectious Disease
     13.10.1.1 HPV Rapid Tests
     13.10.1.2 Hepatitis Rapid Tests
     13.10.1.3 Influenza Rapid Tests
     13.10.1.4 Malaria Rapid Tests
     13.10.1.5 HIV Rapid Tests
     13.10.1.6 COVID - 19
     13.10.1.7 Other Infectious Disease Rapid Tests
   13.10.2 Cardiology
   13.10.3 Oncology
   13.10.4 Pregnancy & Fertility
   13.10.5 Toxicology
   13.10.6 Glucose Monitoring
   13.10.7 Others
  13.11 Basis Point Share (BPS) Analysis By Application
  13.12 Absolute $ Opportunity Assessment By Application
  13.13 Market Attractiveness Analysis By Application
  13.14 Latin America Rapid Tests Kits Market Size Forecast By End-user
   13.14.1 Hospitals & clinics
   13.14.2 Diagnostic laboratories
   13.14.3 Home care
   13.14.4 Others
  13.15 Basis Point Share (BPS) Analysis By End-user
  13.16 Absolute $ Opportunity Assessment By End-user
  13.17 Market Attractiveness Analysis By End-user
Chapter 14 Middle East & Africa (MEA) Rapid Tests Kits Analysis and Forecast
  14.1 Introduction
  14.2 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast by Country
   14.2.1 Saudi Arabia
   14.2.2 South Africa
   14.2.3 UAE
   14.2.4 Rest of Middle East & Africa (MEA)
  14.3 Basis Point Share (BPS) Analysis by Country
  14.4 Absolute $ Opportunity Assessment by Country
  14.5 Market Attractiveness Analysis by Country
  14.6 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By Product
   14.6.1 Over-the-counter (OTC)
   14.6.2 Professional
  14.7 Basis Point Share (BPS) Analysis By Product
  14.8 Absolute $ Opportunity Assessment By Product
  14.9 Market Attractiveness Analysis By Product
  14.10 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By Application
   14.10.1 Infectious Disease
     14.10.1.1 HPV Rapid Tests
     14.10.1.2 Hepatitis Rapid Tests
     14.10.1.3 Influenza Rapid Tests
     14.10.1.4 Malaria Rapid Tests
     14.10.1.5 HIV Rapid Tests
     14.10.1.6 COVID - 19
     14.10.1.7 Other Infectious Disease Rapid Tests
   14.10.2 Cardiology
   14.10.3 Oncology
   14.10.4 Pregnancy & Fertility
   14.10.5 Toxicology
   14.10.6 Glucose Monitoring
   14.10.7 Others
  14.11 Basis Point Share (BPS) Analysis By Application
  14.12 Absolute $ Opportunity Assessment By Application
  14.13 Market Attractiveness Analysis By Application
  14.14 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By End-user
   14.14.1 Hospitals & clinics
   14.14.2 Diagnostic laboratories
   14.14.3 Home care
   14.14.4 Others
  14.15 Basis Point Share (BPS) Analysis By End-user
  14.16 Absolute $ Opportunity Assessment By End-user
  14.17 Market Attractiveness Analysis By End-user
Chapter 15 Competition Landscape
  15.1 Rapid Tests Market: Competitive Dashboard
  15.2 Global Rapid Tests Market: Market Share Analysis, 2020
  15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
   15.3.1 Abbott
   15.3.2 BD
   15.3.3 Bio-Rad Laboratories, Inc.
   15.3.4 Cepheid
   15.3.5 Meridian Bioscience, Inc.
   15.3.6 OraSure Technologies
   15.3.7 Quidel Corporation
   15.3.8 F. Hoffmann-La Roche Ltd.
   15.3.9 Rapikit
   15.3.10 MP Biomedicals
   15.3.11 VedaLab
   15.3.12 Atlas Medical GmbH
   15.3.13 Abingdon Health
   15.3.14 Vitrosens Biotechnology
   15.3.15 Advin Health care

Key Segments Covered

By Products

  • Over-the-Counter (OTC)
  • Professional
By Application
  • Infectious Disease
    • HPV Rapid Tests Kits
    • Hepatitis Rapid Tests Kits
    • Influenza Rapid Tests Kits
    • Malaria Rapid Tests Kits
    • HIV Rapid Tests Kits
    • COVID – 19
    • Other Infectious Disease Rapid Tests Kits
  • Cardiology
  • Oncology
  • Pregnancy & Fertility
  • Toxicology
  • Glucose Monitoring
  • Others
By End-user
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Others
Key Market Players Profiled in the Report
  • Abbott
  • BD
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Meridian Bioscience, Inc.
  • OraSure Technologies
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd.
  • VedaLab
  • Atlas Medical GmbH
  • Abingdon Health
  • Vitrosens Biotechnology
  • Advin Health care
  • Rapikit
  • MP Biomedicals
  • Key players operating in the market are Abbott, BD, Bio-Rad Laboratories, Inc., Cepheid, Meridian Bioscience, Inc., OraSure Technologies, Quidel Corporation, F. Hoffmann-La Roche Ltd. , VedaLab, Atlas Medical GmbH, Abingdon Health, Vitrosens Biotechnology, Advin Health care, Rapikit, and MP Biomedicals. These companies are considered as key manufacturers of rapid test based on their revenue, research development (R&D) activities, product offerings, regional presence, and supply chain management system.
  • The players are adopting key strategies such as acquisition, collaborations, and geographical expansion where potential opportunity for the rapid test market.
  • On December 26, 2020, Abbott’s Binaxnow Covid-19 rapid test received FDA emergency use authorization for first virtually guided, at-home rapid test using EMED'S digital health platform.
  • On February 22 2021, BD collaborated with Scanwell Health for at-home rapid test for Covid-19, using a BD antigen test and the Scanwell Health mobile app.
  •  On March 30 2021, BD received FDA emergency use authorization for BD Veritor System, which is a rapid antigen test that can detect SARS-CoV-2, influenza A, and influenza B in a single test.
Rapid Tests Kits Market by key players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles are provided on request

According to this GMR report, the Rapid Tests Kits market is expected to register a CAGR of 11.3% during the forecast period, 2020-2028, with an anticipated valuation of USD 10,982.9 million by the end of 2028.

In addition to market size (in US$ Million), Company Market Share (in % for base year 2020), Regulatory Landscape, Technology Landscape, Patent Analysis, Consumer Survey, and Pipeline /Clinical Trial Analysis are available in the report.

The Rapid Tests Kits market is projected to expand at a rapid pace globally, owing to the Increasing Prevalence of Infectious Diseases, Sudden Outbreak & Spread of COVID-19, Growing Preference for Home Healthcare, and Rising Geriatric Population.

End-uses of Rapid Tests Kits include Hospitals & Clinics, Diagnostic Laboratories, Home Care, and Others.

The base year considered for the Global Rapid Tests Kits Market report is 2020. The complete analysis period is 2018 to 2028, wherein, 2018 and 2019 are the historic years, and the forecast is provided from 2020 to 2028.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The global rapid test Market was positively impacted by the covid-19, owing to the increase in demand for rapid test kits for COVID testing.

Factors such as Product Launch, Government Initiatives & Regulations, GDP, Healthcare Industry, Prevalence of Diseases, R&D Industry are analyzed in the final report.

Major players include Abbott, BD, Bio-Rad Laboratories, Inc., Cepheid, Meridian Bioscience, Inc., OraSure Technologies, Quidel Corporation, F. Hoffmann-La Roche Ltd. , VedaLab, Atlas Medical GmbH, Abingdon Health, Vitrosens Biotechnology, Advin Health care, Rapikit, and MP Biomedicals, and others.